INNO-LIA ANA UPDATE
Mexico·Clase II·III. DIAGNOSTIC AGENTS·ASESORES MÉDICOBIOLÓGICOS, S.A. DEC.V.·Registered September 27, 2021INNO-LIA ANA UPDATE ES UNINMUNOENSAYO DE LÍNEA PARA LADETECCIÓN E IDENTIFICACIÓN DE TRECEANTICUERPOS ANTINUCLEARES (ANA) EN ELSUERO HUMANO PARA AYUDAR EN ELDIAGNÓSTICO DE TRASTORNOS DEL TEJIDOCONECTIVO.
INNO-LIA ANA UPDATE IS A LINE-LINE IMMUNOASSAY FOR THE DETECTION AND IDENTIFICATION OF THIRTEEN ANTINUCLEAR ANTIBODIES (ANA) IN HUMAN SERUM TO AID IN THE DIAGNOSIS OF CONNECTIVE TISSUE DISORDERS.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- INMUNOENSAYO PARA LA DETECCIÓN EIDENTIFICACIÓN DE TRECE ANTICUERPOSANTINUCLEARES (ANA)
- Trade Name (English)
- IMMUNOASSAY FOR THE DETECTION AND IDENTIFICATION OF THIRTEEN ANTIBODIESANTINUCLEAR (ANA)
- Analysis ID
- 1492R2021 SSA
- Registration Date
- September 27, 2021
- Name (Spanish)
- ASESORES MÉDICOBIOLÓGICOS, S.A. DEC.V.
- Name (English)
- ASESORES MÉDICOBIOLÓGICOS, S.A. DEC.V.
Access comprehensive regulatory information for INNO-LIA ANA UPDATE (INNO-LIA ANA UPDATE) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1492R2021 SSA and manufactured by ASESORES MÉDICOBIOLÓGICOS, S.A. DEC.V.. The device was registered on September 27, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.